Jul-Sep 2021;14(3):307-312
Among these, clinical trials underscore the need to monitor adverse events and consider patient-specific factors when administering retatrutide
B., Renstrm, F., Aczl, S., Folie, P., Biraima-Steinemann, M., Beuschlein, F., & Bilz, S
A provider may recommend semaglutide based on medical history, side effect tolerance, insurance coverage, or prior response to treatment
Prior authorization is required for GLP-1 medications to ensure that they are medically necessary and that the insurance company is covering treatments that align with their approved guidelines
Utilizing Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), we performed post-translational modification analysis on NHR-49::GFP immunoprecipitations 42 under fed and fasted states and identified a single phosphorylation event with high confidence within the receptors hinge region at serine 114 (Fig